Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ulrich W. Kolck"'
Autor:
Myriam Schafigh, Farhad Bakhtiary, Ulrich W. Kolck, Sebastian Zimmer, Susanne Greschus, Miriam Silaschi
Publikováno v:
JACC: Case Reports. 4:1522-1528
Publikováno v:
Translational research 174, 23-32.e1 (2016). doi:10.1016/j.trsl.2015.12.012
Traditionally, mast cell activation disease (MCAD) has been considered as just one rare (neoplastic) disease, mastocytosis, focused on the mast cell (MC) mediators tryptase and histamine and the suggestive, blatant symptoms of flushing and anaphylaxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e58edb053ef55b70894ad7347206499e
https://pub.dzne.de/record/138686
https://pub.dzne.de/record/138686
Autor:
U. Haars, Kirsten Meis, Thomas Frieling, Holger Seidel, Ulrich W. Kolck, Hans-Jörg Hertfelder, A. Hülsdonk, Gerhard J. Molderings, Jürgen Homann, Johannes Oldenburg
Publikováno v:
Zeitschrift für Gastroenterologie. 49:191-194
Previous findings suggested an involvement of mast cells in the pathogenesis of irritable bowel syndrome (IBS). The pathophysiological significance of mast cells is defined both by their number in tissue and by their activity. In the present pilot st
Publikováno v:
Immunogenetics. 62:721-727
Systemic mast cell activation syndrome is a mast cell disorder characterized by an unregulated increased activation of mast cells leading to a pathologically enhanced release of mediators. Mutations in tyrosine kinase kit which crucially determines m
Autor:
Jürgen Homann, Gerhard J. Molderings, Andreas Ehnes, Thomas Frieling, Ulrich W. Kolck, Martin Raithel
Publikováno v:
Medizinische Klinik. 105:544-553
Systemic mastocytosis comprises disorders characterized by an accumulation of genetically altered mast cells in all organs and tissues due to an increased proliferation rate and reduced apoptosis of those pathologic mast cells. Release of their media
Autor:
Gerhard J. Molderings, Christian Scheurlen, Michael Brüss, Jürgen Homann, Ulrich W. Kolck, Ivar Von Kügelgen
Publikováno v:
Scandinavian Journal of Gastroenterology. 42:1045-1053
Objective. Sequencing efforts to discover mutations in the tyrosine kinase Kit related to systemic mast cell disorders have so far been focused mainly on only a few of the 21 exons of the encoding gene c-kit, thus considerably limiting the possibilit
Autor:
Martin Raithel, Thomas Frieling, Ulrich W. Kolck, Jürgen Homann, Gerhard J. Molderings, C. Scheurlen, M. Brüss
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 131:2095-2100
Eine systemische Mastzellerkrankung manifestiert sich unter anderem haufig in Form von episodischen oder chronischen unspezifischen gastrointestinalen Beschwerden. Krankhaft veranderte Mastzellen, die aufgrund genetischer Mutationen eine erhohte Prol
Autor:
Gerhard J. Molderings, Kirsten Meis, Jürgen Homann, Johannes Oldenburg, Holger Seidel, Ulrich W. Kolck, Hans-Jörg Hertfelder
Publikováno v:
Thrombosis and haemostasis. 106(5)
Autor:
Jürgen, Homann, Ulrich W, Kolck, Andreas, Ehnes, Thomas, Frieling, Martin, Raithel, Gerhard J, Molderings
Publikováno v:
Medizinische Klinik (Munich, Germany : 1983). 105(8)
Systemic mastocytosis comprises disorders characterized by an accumulation of genetically altered mast cells in all organs and tissues due to an increased proliferation rate and reduced apoptosis of those pathologic mast cells. Release of their media
Publikováno v:
Deutsches Ärzteblatt international.
In their review article on systemic mastocytoses, Horny et al. consider the 2001 diagnostic criteria of the World Health Organization (WHO) as the gold standard for diagnosing systemic mastocytosis. In view of today’s insights into mast cell pathol